167 related articles for article (PubMed ID: 3123510)
1. Serum bioactive and immunoreactive follicle-stimulating hormone in prostatic cancer patients during gonadotropin-releasing hormone agonist treatment and after orchidectomy.
Huhtaniemi IT; Dahl KD; Rannikko S; Hsueh AJ
J Clin Endocrinol Metab; 1988 Feb; 66(2):308-13. PubMed ID: 3123510
[TBL] [Abstract][Full Text] [Related]
2. The ratios of serum bioactive/immunoreactive luteinizing hormone and follicle-stimulating hormone in various clinical conditions with increased and decreased gonadotropin secretion: reevaluation by a highly sensitive immunometric assay.
Jaakkola T; Ding YQ; Kellokumpu-Lehtinen P; Valavaara R; Martikainen H; Tapanainen J; Rönnberg L; Huhtaniemi I
J Clin Endocrinol Metab; 1990 Jun; 70(6):1496-505. PubMed ID: 2140831
[TBL] [Abstract][Full Text] [Related]
3. Response of circulating gonadotropin levels to GnRH agonist treatment in prostatic cancer.
Huhtaniemi I; Venho P; Jacobi G; Rannikko S
J Androl; 1991; 12(1):46-53. PubMed ID: 1901309
[TBL] [Abstract][Full Text] [Related]
4. Pituitary-testicular function of prostatic cancer patients during treatment with a gonadotropin-releasing hormone agonist analog. I. Circulating hormone levels.
Huhtaniemi I; Nikula H; Rannikko S
J Androl; 1987; 8(6):355-62. PubMed ID: 3123445
[TBL] [Abstract][Full Text] [Related]
5. Treatment of prostatic cancer with a gonadotropin-releasing hormone agonist analog: acute and long term effects on endocrine functions of testis tissue.
Huhtaniemi I; Nikula H; Rannikko S
J Clin Endocrinol Metab; 1985 Oct; 61(4):698-704. PubMed ID: 2993345
[TBL] [Abstract][Full Text] [Related]
6. Effects of oestrogen treatment on serum gonadotrophin bioactivity, immunoreactivity and isohormone distribution, and on immunoreactive inhibin levels, in prostatic cancer patients.
Matikainen T; Haavisto AM; Permi J; de Kretser D; Huhtaniemi I
Clin Endocrinol (Oxf); 1994 Jun; 40(6):743-50. PubMed ID: 8033364
[TBL] [Abstract][Full Text] [Related]
7. Differing responses of plasma bioactive and immunoreactive follicle-stimulating hormone and luteinizing hormone to gonadotropin-releasing hormone antagonist and agonist treatments in postmenopausal women.
Matikainen T; Ding YQ; Vergara M; Huhtaniemi I; Couzinet B; Schaison G
J Clin Endocrinol Metab; 1992 Sep; 75(3):820-5. PubMed ID: 1517372
[TBL] [Abstract][Full Text] [Related]
8. More basic isoforms of serum gonadotropins during gonadotropin-releasing hormone agonist therapy in pubertal children.
Wide L; Albertsson-Wikland K; Phillips DJ
J Clin Endocrinol Metab; 1996 Jan; 81(1):216-21. PubMed ID: 8550754
[TBL] [Abstract][Full Text] [Related]
9. Maintenance of the ratio of bioactive to immunoreactive follicle-stimulating hormone in normal men during chronic luteinizing hormone-releasing hormone agonist administration.
Pavlou SN; Dahl KD; Wakefield G; Rivier J; Vale W; Hsueh AJ; Lindner J
J Clin Endocrinol Metab; 1988 May; 66(5):1005-9. PubMed ID: 2834409
[TBL] [Abstract][Full Text] [Related]
10. The changing ratio of serum bioactive to immunoreactive follicle-stimulating hormone in normal men following treatment with a potent gonadotropin releasing hormone antagonist.
Dahl KD; Pavlou SN; Kovacs WJ; Hsueh AJ
J Clin Endocrinol Metab; 1986 Sep; 63(3):792-4. PubMed ID: 3090097
[TBL] [Abstract][Full Text] [Related]
11. Hormonal effects of gonadotropin-releasing hormone (GnRH) agonist in the human male. III. Effects of long term combined treatment with GnRH agonist and androgen.
Bhasin S; Heber D; Steiner BS; Handelsman DJ; Swerdloff RS
J Clin Endocrinol Metab; 1985 May; 60(5):998-1003. PubMed ID: 3920237
[TBL] [Abstract][Full Text] [Related]
12. Serum bioactive follicle-stimulating hormone levels in girls with precocious sexual development.
Wang C; Zhong CQ; Leung A; Low LC
J Clin Endocrinol Metab; 1990 Mar; 70(3):615-9. PubMed ID: 2106526
[TBL] [Abstract][Full Text] [Related]
13. Granulosa cell aromatase bioassay for follicle-stimulating hormone: validation and application of the method.
Jia XC; Hsueh AJ
Endocrinology; 1986 Oct; 119(4):1570-7. PubMed ID: 2428600
[TBL] [Abstract][Full Text] [Related]
14. Hormonal effects of gonadotropin-releasing hormone (GnRH) agonist in men: effects of long term treatment with GnRH agonist infusion and androgen.
Bhasin S; Yuan QX; Steiner BS; Swerdloff RS
J Clin Endocrinol Metab; 1987 Sep; 65(3):568-74. PubMed ID: 3114307
[TBL] [Abstract][Full Text] [Related]
15. Serum bioactive and immunoreactive follicle-stimulating hormone levels and the response to clomiphene in healthy young and elderly men.
Tenover JS; Dahl KD; Hsueh AJ; Lim P; Matsumoto AM; Bremner WJ
J Clin Endocrinol Metab; 1987 Jun; 64(6):1103-8. PubMed ID: 3106393
[TBL] [Abstract][Full Text] [Related]
16. Gonadotropin-releasing hormone regulates follicle-stimulating hormone beta-subunit gene expression in the male rat.
Rodin DA; Lalloz MR; Clayton RN
Endocrinology; 1989 Sep; 125(3):1282-9. PubMed ID: 2503366
[TBL] [Abstract][Full Text] [Related]
17. Serum bioactive and immunoreactive follicle stimulating hormone during chronic treatment with gonadotropin releasing hormone agonist in elderly men.
Matzkin H; Braf Z; Dekel N
Horm Metab Res; 1991 Feb; 23(2):76-80. PubMed ID: 1710593
[TBL] [Abstract][Full Text] [Related]
18. Recovery of hormone secretion after chronic gonadotropin-releasing hormone agonist administration in women with polycystic ovarian disease.
de Ziegler D; Steingold K; Cedars M; Lu JK; Meldrum DR; Judd HL; Chang RJ
J Clin Endocrinol Metab; 1989 Jun; 68(6):1111-7. PubMed ID: 2524501
[TBL] [Abstract][Full Text] [Related]
19. Serum luteinizing hormone (LH) biological activity in castrated patients with cancer of the prostate receiving a pure antiandrogen and in estrogen-pretreated patients treated with an LH-releasing hormone agonist and antiandrogen.
St Arnaud R; Lachance R; Dupont A; Labrie F
J Clin Endocrinol Metab; 1986 Aug; 63(2):297-302. PubMed ID: 3522618
[TBL] [Abstract][Full Text] [Related]
20. Gonadotroph adenomas in men produce biologically active follicle-stimulating hormone.
Galway AB; Hsueh AJ; Daneshdoost L; Zhou MH; Pavlou SN; Snyder PJ
J Clin Endocrinol Metab; 1990 Oct; 71(4):907-12. PubMed ID: 2119391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
